Friday, February 22, 2013

Holy Wedding Bells! Batwoman Proposes to Girlfriend

Will wedding bells be ringing in Batwoman?s future?

According to Bleeding Cool, the latest issue of the lesbian caped crusader?s solo series suggests it?s a strong possibility.

In Batwoman #17, published today, Kate Kane (Batwoman) proposes to her secret girlfriend Maggie Sawyer.

The issue marks another historic milestone for LGBT representation in the media genre as it contains the first lesbian proposal in a mainstream comic book.

Followers of Batwoman artist J.H. Williams III were treated to a hint via Twitter before the issue?s release that an important chapter in the life of DC?s leading lesbian lady would be going down this week. He also expressed why the character has come to mean so much to him and fans alike on his personal website on Tuesday. "Batwoman is an important character, and a socially important one that has meaning that extends well beyond the printed pages of the world she lives in, reaching out into ours possibly affecting those who encounter her story."

Positive buzz about one of the highest profile LGBT superheroes in comics today will undoubtedly be welcomed by DC, as the latest developments in Batwoman have unfolded on the heels of the publisher?s earlier controversial announcement that antigay advocate Orson Scott Card would pen the new anthology comic book series Adventures of Superman.

Source: http://www.gay.net/hot-reads/2013/02/20/holy-wedding-bells-batwoman-proposes-girlfriend

space shuttle enterprise ryan leaf ryan leaf luke kuechly brad miller chandler jones peyton hillis

Thursday, February 21, 2013

3.5m downloads on, CloudOn takes its Microsoft Office editing suite to Android smartphones

CloudOn, the mobile app for creating, editing and managing Microsoft Office and Adobe documents in the cloud, has today announced the launch of version4.0 of its productivity workspace, which sees it finally rolled out for Android smartphones.

Just to recap, CloudOn taps Dropbox, Box, Google Drive and ? since December ? SkyDrive integration, to deliver full Microsoft Office capabilities, transforming tablets and smartphones into mobile workspaces capable of accessing Office documents on the go. The app uses cloud technology to connect to Microsoft Office software on CloudOn?s servers, so in effect your device is used as a screen.

While it was already available for Android tablets, with this latest launch, CloudOn now lets users create and edit Word documents, Excel spreadsheets and PowerPoint presentations from their handheld Android device, and compatible handsets for the timebeing will be the Samsung Galaxy S III, Galaxy S II Skyrocket, Galaxy Nexus, Galaxy Note, Galaxy Note II and the Galaxy Nexus 4G LTE, though more will be added in due course.

a5 220x391 3.5m downloads on, CloudOn takes its Microsoft Office editing suite to Android smartphones???? b5 220x391 3.5m downloads on, CloudOn takes its Microsoft Office editing suite to Android smartphones

The Android smartphone incarnation offers similar functionality to the version available on other platforms, and the look, feel and functionality will be familiar to anyone who uses Office on a regular basis.

The app also draws on an Android-customized Microsoft office ribbon, tailored so that touch-reliant functions such as changing the size of a font or enabling tracked changes are made easier.

c1 220x391 3.5m downloads on, CloudOn takes its Microsoft Office editing suite to Android smartphones??? d1 220x391 3.5m downloads on, CloudOn takes its Microsoft Office editing suite to Android smartphones

With version 4,.0, CloudOn is also including landscape mode which, let?s face it, is particularly vital to minimize scrolling in smaller-screened devices.

e1 520x292 3.5m downloads on, CloudOn takes its Microsoft Office editing suite to Android smartphones

In addition, the latest smartphone version includes CloudOn FileSpace, which is where users can add notes and view all their activity on a single file, including edits, for real-time updates on documents.

Back in June last year, CloudOn raised $16m in Series B funding to help it move beyond ?Office for tablets?. This was announced a few weeks after it rolled out in fifteen countries across Europe and in Israel, and then landed in an additional 60 countries globally followed by 12 more in Latin America. To mark today?s launch, the Palo Alto-based company has also announced 3.5 million downloads to date.

The new Android app is live now.

? CloudOn | Android (Smartphones)

Source: http://thenextweb.com/apps/2013/02/21/3-5m-downloads-on-cloudon-takes-its-microsoft-office-editing-suite-to-android-smartphones/

Don Grady ann curry euro 2012 Colorado Springs pga tour Nora Ephron mario balotelli

Wednesday, February 20, 2013

New injectable hydrogel encourages regeneration and improves functionality after a heart attack

Feb. 20, 2013 ? University of California, San Diego bioengineers have demonstrated in a study in pigs that a new injectable hydrogel can repair damage from heart attacks, help the heart grow new tissue and blood vessels, and get the heart moving closer to how a healthy heart should. The results of the study were published Feb. 20 in Science Translational Medicine and clear the way for clinical trials to begin this year in Europe. The gel is injected through a catheter without requiring surgery or general anesthesia -- a less invasive procedure for patients.?

There are an estimated 785,000 new heart attack cases in the United States each year, with no established treatment for repairing the resulting damage to cardiac tissue. Lead researcher Karen Christman, a professor in the Department of Bioengineering at the UC San Diego Jacobs School of Engineering, said the gel forms a scaffold in damaged areas of the heart, encouraging new cell growth and repair. Because the gel is made from heart tissue taken from pigs, the damaged heart responds positively, creating a harmonious environment for rebuilding, rather than setting off a chain of adverse immune system defenses.

"While more people today are initially surviving heart attacks, many will eventually go into heart failure," said Christman. "Our data show that this hydrogel can increase cardiac muscle and reduce scar tissue in the region damaged by the heart attack, which prevents heart failure. These results suggest this may be a novel minimally invasive therapy to prevent heart failure after a heart attack in humans."

The hydrogel is made from cardiac connective tissue that is stripped of heart muscle cells through a cleansing process, freeze-dried and milled into powder form, and then liquefied into a fluid that can be easily injected into the heart. Once it hits body temperature, the liquid turns into a semi-solid, porous gel that encourages cells to repopulate areas of damaged cardiac tissue and to improve heart function, according to Christman. The material is also biocompatible; animals treated with the hydrogel suffered no adverse affects such as inflammation, lesions or arrhythmic heart beating, according to safety experiments conducted as part of the study. Further tests with human blood samples showed that the gel had no affect on the blood's clotting ability, which underscores the biocompatibility of the treatment for use in humans.

San Diego-based startup, Ventrix, Inc., which Christman co-founded, has licensed the technology for development and commercialization. Christman also serves on the company's board. "We are excited and encouraged by the results of the study leading to a novel regenerative medicine solution for cardiac repair. The technology offers the potential for a longer and better quality of life for millions of heart attack sufferers," said Adam Kinsey, the CEO of Ventrix.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:


Story Source:

The above story is reprinted from materials provided by University of California - San Diego.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Journal Reference:

  1. S. B. Seif-Naraghi, J. M. Singelyn, M. A. Salvatore, K. G. Osborn, J. J. Wang, U. Sampat, O. L. Kwan, G. M. Strachan, J. Wong, P. J. Schup-Magoffin, R. L. Braden, K. Bartels, J. A. DeQuach, M. Preul, A. M. Kinsey, A. N. DeMaria, N. Dib, K. L. Christman. Safety and Efficacy of an Injectable Extracellular Matrix Hydrogel for Treating Myocardial Infarction. Science Translational Medicine, 2013; 5 (173): 173ra25 DOI: 10.1126/scitranslmed.3005503

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

Source: http://feeds.sciencedaily.com/~r/sciencedaily/top_news/~3/DRu8rtKe_yc/130220153705.htm

pro bowl 2012 rick santorum daughter gainesville 2012 royal rumble the grey machine gun kelly saul alinsky

Boston's sandal-wearing cardinal gets papal buzz

AFP - Getty Images file

Boston Cardinal Sean O'Malley, shown here at a 2009 press conference, is generating buzz ahead of the papal conclave in Rome.

By Tracy Connor, Staff Writer, NBC News

Boston Cardinal Sean O'Malley is generating buzz in Rome as a possible contender to be the next pope, even though Vatican watchers have long said an American pontiff is a longshot.

John L. Allen, a columnist for the National Catholic Reporter, took note this week of the growing number of Italian newspapers and commentators who have mentioned O'Malley as a candidate or written favorably about his cleanup of the archdiocese's sex-abuse scandal.

"Right now, it's tough for an American journalist to walk into the Vatican Press Office without fielding questions from colleagues about him," Allen wrote.

O'Malley -- a distinctive figure in the monkish brown cassock of the Capuchin religious order -- isn't entertaining questions about his chances of succeeding Pope Benedict XVI when the College of Cardinals convenes.

"As the Cardinal said last week at his press conference, he has a round trip ticket to return home and will rely on the guidance and wisdom of the Holy Spirit as the College of Cardinals enter the conclave in March," spokeswoman Kellyanne Dignan said.

O'Malley, 68, was named archbishop of Boston in 2003, after Cardinal Bernard Law stepped down amid allegations he covered up sex abuse by priests. He was elevated to cardinal three years later.?

Thomas Groome, a theology professor at Boston College, said that of all the American bishops who've had to deal with the abuse crisis, O'Malley "has come closest to satisfying the victims." He sold the archdiocese's palatial headquarters and used the money for victim settlements.

A low-key personality who prizes simplicity and "isn't a hardened idealogue," O'Malley would bring a starkly different style to the papacy, Groome said.

"We'd go from Prada booties to sandals and no socks," he said. "He wouldn't be a blustering public personality like John Paul. You'd have to go back to John XXIII to find someone analogous."

Groome said that when O'Malley's name surfaced he initially laughed it off but now thinks he could emerge as the next pope from a brokered conclave where the cardinals from the northern and southern hemispheres square off.

Franco Origlia / Getty Images file

Cardinal Sean Patrick O'Malley, archbishop of Boston, attends a concistory held by Pope Benedict at Saint Peter's Basilica on November 24, 2012, in Vatican City, Vatican.

"There are 117 cardinals and probably 116 of them would love to be pope," he said. "The one who wouldn't is O'Malley and that could be why he gets it."

Rocco Palmo, who writes the popular Whispers in the Loggia blog, noted that O'Malley heads the U.S. Conference of Catholic Bishops' high-profile pro-life committee, giving him exposure outside his Boston archdiocese.

But he said it's way too soon to say he's on a short-list.

"It's a wide open field, and anything is possible," Palmo said. "But there are 117 voting cardinals and in the next 25 days, I expect to hear every one of those cardinals' names mentioned."

O'Malley is no Vatican insider and some will question whether he has the managerial mettle to accomplish a much-needed overhaul of its sprawling bureaucracy. And there's never been a pope from the Capuchin order of friars, who are noted for their service to the poor.?

It's been conventional wisdom that American cardinals have little chance of being the pope because of a global phobia of a U.S.-dominated Vatican. Allen says that may have changed because the country's superpower status has dimmed over the decades.

"The Americans have the second-largest voting bloc -- 11 -- after the Italians," Palmo said. "It's only natural an American name is going to appear at some point."

Previously, New York Cardinal Timothy Dolan was mentioned by many as America's top papal possibility. He says those predictions are off-base.

?Those are only from people smoking marijuana,? Dolan said Sunday at St. Patrick's Cathedral.

Javier Barbancho / AFP - Getty Images

Joseph Ratzinger became Pope Benedict XVI in 2005. Look back at his life from childhood through his papacy.

Source: http://usnews.nbcnews.com/_news/2013/02/20/17031704-bostons-sandal-wearing-cardinal-omalley-getting-papal-buzz?lite

ryan oneal file taxes online tupac shakur sledge hammer tax day freebies madison bumgarner wnba draft

Genome-wide imaging study identifies new gene associated with Alzheimer's plaques

Feb. 20, 2013 ? A study combining genetic data with brain imaging, designed to identify genes associated with the amyloid plaque deposits found in Alzheimer's disease patients, has not only identified the APOE gene -- long associated with development of Alzheimer's -- but has uncovered an association with a second gene, called BCHE.

A national research team, led by scientists at the Indiana University School of Medicine, reported the results of the study in an article in Molecular Psychiatry posted online February 19. The study is believed to be the first genome-wide association study of plaque deposits using a specialized PET scan tracer that binds to amyloid.

The research also is believed to be the first to implicate variations in the BCHE gene in plaque deposits visualized in living individuals who have been diagnosed with Alzheimer's disease or are at-risk for developing the disease. The enzyme coded by the BCHE gene has previously been studied in post-mortem brain tissue and is known to be found in plaques.

"The findings could recharge research efforts studying the molecular pathways contributing to amyloid deposits in the brain as Alzheimer's disease develops and affects learning and memory," said Vijay K. Ramanan, the paper's first author and an M.D./Ph.D. student at the IU School of Medicine.

The BCHE gene finding "brings together two of the major hypotheses about the development of Alzheimer's disease," said Andrew J. Saykin, Psy.D., Raymond C. Beeler Professor of Radiology and Imaging Sciences at IU and principal investigator for the genetics core of the Alzheimer's Disease Neuroimaging Initiative.

Scientists have long pointed to the loss of an important brain neurotransmitter, acetylcholine, which is depleted early in the development of the disease, as a key aspect of the loss of memory related neurons. The BCHE gene is responsible for an enzyme that breaks down acetylcholine in the brain. The other major Alzheimer's hypothesis holds that the development of the amyloid plaques is the primary cause of the disease's debilitating symptoms. As it turns out, the enzyme for which the BCHE gene codes is also found in significant quantities in those plaques.

"This study is connecting two of the biggest Alzheimer's dots," said Dr. Saykin, director of the Indiana Alzheimer Disease Center and the IU Center for Neuroimaging at the IU Health Neuroscience Center.

"The finding that BCHE gene variant predicts the extent of plaque deposit in PET scans among people at risk for Alzheimer's disease is likely to reinvigorate research into drugs that could modify the disease by affecting the BCHE enzyme or its metabolic pathway," he said. Some existing drugs inhibit this enzyme, but it is unclear whether this influences plaque deposits.

Overall, the results appear to offer scientists new potential targets for drugs to slow, reverse or even prevent the disease. Alzheimer's disease affects an estimated 5.4 million Americans and has proven resistant to treatments that do more than temporarily slow the worsening of symptoms.

Amyloid plaque deposits build up abnormally in the brains of Alzheimer's patients and are believed to play an important role in the memory loss and other problems that plague patients.

The study makes use of an imaging agent, florbetapir, now approved for use by the U.S. Food and Drug Administration, that allows physicians to see the level of plaque buildup in a patient's brain, something that previously could be determined only with an autopsy.

In a genome-wide association study, researchers evaluate alternate versions of many genes to determine whether particular genetic variants are associated with a particular trait -- in this case, the amounts of amyloid plaque deposits that the PET scans revealed in the brains of study participants.

Using the imaging agent that enables detection of the plaques in the brain, the researchers conducted PET scans of 555 participants in the Alzheimer's Disease Neuroimaging Initiative, a long-term public-private research project that includes people at risk for Alzheimer's disease and patients who have been diagnosed with the disease as well as participants with no symptoms.

With sophisticated statistical analyses, the imaging data was combined with analyses of DNA collected from the 555 participants to determine whether particular gene variants were found more often among patients with higher levels of plaque deposits.

The analysis found that a variant in BCHE was significantly associated with the levels of plaque deposits. As would be expected, the analysis also found a strong association with variants of another gene, APOE, that has long been known to be associated with the development of Alzheimer's. The effect of BCHE was independent of APOE, however. Moreover, the effects of the two genes were additive -- that is, people with the suspect variants of both genes had more plaque deposits than people who had only one of the variants associated with plaque development.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:


Story Source:

The above story is reprinted from materials provided by Indiana University.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Journal Reference:

  1. V K Ramanan, S L Risacher, K Nho, S Kim, S Swaminathan, L Shen, T M Foroud, H Hakonarson, M J Huentelman, P S Aisen, R C Petersen, R C Green, C R Jack, R A Koeppe, W J Jagust, M W Weiner, A J Saykin. APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study. Molecular Psychiatry, 2013; DOI: 10.1038/mp.2013.19

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

Source: http://feeds.sciencedaily.com/~r/sciencedaily/top_news/~3/lcMKpbKxQM4/130220153701.htm

los angeles kings earth day timothy leary jonathan frid pujols watchmen hitch

Wednesday, January 30, 2013

Fleksy Is an Alternative Keyboard Even the Blind Can Use

Fleksy Is an Alternative Keyboard Even the Blind Can UseiOS: Fleksy is an alternative keyboard with unprecedented predictive text skills. You can type a word completely wrong and it'll still figure out what you meant.

That's because Fleksy was designed with the blind in mind. The keyboard not only fixes your grievous typing errors, but speaks back the word to you so you know what it thinks you typed. The keyboard only consists of letters, however. To make a space you swipe right. To delete a word you swipe left. You can add punctuation by pressing and holding the keyboard to reveal a new row, or you can just make two spaces to create a period, then swipe down to change it to a question mark, exclamation point, or something else. While Fleksy takes a little getting used to at first, it's a very effective way to type because you can throw accuracy out the window pretty much entirely. The only thing it does require is that you know how to spell, otherwise it can't really figure out what you meant. If you're blind or just an awful mobile typer but have good spelling skills, this is the keyboard for you. Of course, it's an app an doesn't integrate full with the OS but you can use it to type out messages and copy/paste the text in elsewhere with all the extra time you'll save.

Fleksy (Free) | iTunes App Store

Source: http://feeds.gawker.com/~r/lifehacker/full/~3/yPwnglZriJg/fleksy-is-an-alternative-keyboard-even-the-blind-can-use

touch nitrous oxide rihanna thug life tattoo arizona governor patrick witt leprosy tampa bay buccaneers

Baig review: Microsoft wants you to pay as you go for new Office

Sorry, Readability was unable to parse this page for content.

Source: http://www.delawareonline.com/article/20130130/BUSINESS09/301300027/1003/RSS01

asteroid mining memorial day ivan rodriguez planetary resources mothers day gift ideas natalee holloway scotty mccreery